[1] Cools M. Germ cell cancer risk in DSD patients. Ann d’Endocrinol , 2014, 75(2): 67-71. [2] Scully RE. Gonadoblastoma. A gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer , 1953, 6(3): 455-463. [3] Ulbright TM, Young RH. Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development. Semin Diagn Pathol , 2014, 31(5): 427-440. [4] Cools M, Stoop H, Kersemaekers AMF, Drop SLS, Wolffenbuttel KP, Bourguignon JP, Slowikowska-Hilczer J, Kula K, Faradz SMH, Oosterhuis JW, Looijenga LHJ. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab , 2006, 91(6): 2404-2413. [5] Cools M, Looijenga LHJ, Wolffenbuttel KP, T’Sjoen G. Managing the risk of germ cell tumourigenesis in disorders of sex development patients. Endocr Dev , 2014, 27: 185-196 [6] Kitsiou-Tzeli S, Deligiorgi M, Malaktari-Skarantavou S, Vlachopoulos C, Megremis S, Fylaktou I, Traeger-Synodinos J, Kanaka-Gantenbein C, Stefanadis C, Kanavakis E. Sertoli cell tumor and gonadoblastoma in an untreated 29-year-old 46, XY phenotypic male with Frasier syndrome carrying a WT1 IVS9+4C>T mutation. Hormones , 2012, 11(3): 361-367. [7] Gómez Llorente JL, Hernández IA, Muñoz Sánchez MD, de Cabo JM, Perales AB. Early presentation of bilateral gonadoblastoma in Turner syndrome. J Pediatr Hematol Oncol , 2013, 35(3): 240-241. [8] Du X, Zhang XH, Li YM, Han YK. 46, XY female sex reversal syndrome with bilateral gonadoblastoma and dysgerminoma. Exp Ther Med , 2014, 8(4): 1102-1104. [9] Kao CS, Ulbright TM, Idrees MT. Gonadoblastoma: an immunohistochemical study and comparison to Sertoli cell nodule with intratubular germ cell neoplasia, with pathogenetic implications. Histopathology , 2014, 65(6): 861-867. [10] Ulbright TM. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update. Int J Gynecol Pathol , 2014, 33(4): 365-373. [11] Gorosito M, Pancera B, Sarancone S, Nocito AL. Gonadoblastoma: an unusual ovarian tumor. Ann Diagn Pathol , 2010, 14(4): 247-250. [12] Palma I, Garibay N, Pena-Yolanda R, Contreras A, Raya A, Dominguez C, Romero M, Aristi G, Queipo G. Utility of OCT3/4, TSPY and β -catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads. Dis Markers , 2013, 34(6): 419-424. [13] Li S, Mo CJ, Huang S, Yang S, Lu Y, Peng QL, Wang J, Deng Y, Qin X, Liu YK. Over-expressed Testis-specific Protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma. PLoS One , 2014, 9(2): e89219. [14] Van der Zwan YG, Biermann K, Wolffenbuttel KP, Cools M, Looijenga LHJ. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. Eur Urol , 2015, 67(4): 692-701. [15] Peña-Alonso R, Nieto K, Alvarez R, Palma I, Nájera N, Eraña L, Dorantes LM, Kofman-Alfaro S, Queipo G. Distribution of Y-chromosome-bearing cells in gonadoblastoma and dysgenetic testis in 45, X/46, XY infants. Mod Pathol , 2005, 18(3): 439-445. [16] Larney C, Bailey TL, Koopman P. Switching on sex: transcriptional regulation of the testis-determining gene Sry . Development , 2014, 141(11): 2195-2205. [17] 裴开颜, 王介东. Y染色体性别决定区( SRY ): 性别决定关键开关. 生殖医学杂志, 2012, 21(4): 400-405. [18] Shahid M, Dhillion VS, Jain N, Hedau S, Diwakar S, Sachdeva P, Batra S, Das BC, Husain SA. Two new novel point mutations localized upstream and downstream of the HMG box region of the SRY gene in three Indian 46, XY females with sex reversal and gonadal tumour formation. Mol Hum Reprod , 2004, 10(7): 521-526. [19] Helszer Z, Dmochowska A, Szemraj J, Słowikowska- Hilczer J, Wieczorek M, Jędrzejczyk S, Kałużewski B. A novel mutation (c. 341A>G) in the SRY gene in a 46, XY female patient with gonadal dysgenesis. Gene , 2013, 526(2): 467-470. [20] Hersmus R, de Leeuw BH, Stoop H, Bernard P, van Doorn HC, Brüggenwirth HT, Drop SL, Oosterhuis JW, Harley VR, Looijenga LH. A novel SRY missense mutation affecting nuclear import in a 46, XY female patient with bilateral gonadoblastoma. Eur J Hum Genet , 2009, 17(2): 1642-1649. [21] Kim J, Kim SH, Song J, Choi JR, Kim HS, Lee KA. An SRY -deleted XXY female resulting from a paternally inherited t(Y;22). Ann Clin Lab Sci, 2010, 40(3): 295-299. [22] Aviv H, Heller D, Fajardo A, Hoot A, Mavaro L. Sex chromosome mosaicism in gonads of a fetus with cystic hygroma and deletion of the short arm of Y chromosome including loss of SRY . Am J Med Genet , 2001, 102(2): 157-160. [23] O’Connell SM, Lynch SA, Coyle D, McDermott M, O’Sullivan M, Roche E, Quinn F, Cody D. The incidence of childhood gonadoblastoma over 15 years in the Republic of Ireland. ESPE Abstracts , 2014, 1(2): 211. [24] Bianco B, Lipay M, Guedes A, Oliveira K, Verreschi ITN. SRY gene increases the risk of developing gonadoblastoma and/or nontumoral gonadal lesions in Turner syndrome. Int J Gynecol Pathol , 2009, 28(2): 197-202. [25] Lindstedt I, Lindgren MA, Andersson E, Engstrom W. The WT1 gene-its role in tumourigenesis and prospects for immunotherapeutic advances. In Vivo , 2014, 28(5): 675-681. [26] Bagchi D, Andrade J, Shupnik MA. A new role for wilms tumor protein 1: differential activities of + KTS and -KTS variants to regulate LHβ transcription. PLoS One , 2015, 10(1): e0116825. [27] Hersmus R, van der Zwan YG, Stoop H, Bernard P, Sreenivasan R, Oosterhuis JW, Brüggenwirth HT, de Boer S, White S, Wolffenbuttel KP, Alders M, McElreavy K, Drop SLS, Harley VR, Looijenga LH. A 46, XY female DSD patient with bilateral gonadoblastoma, a novel SRY missense mutation combined with a WT1 KTS splice-site mutation. PLoS One , 2012, 7(7): e40858. [28] Denamur E, Bocquet N, Baudouin V, Da Silva F, Veitia R, Peuchmaur M, Elion J, Gubler MC, Fellous M, Niaudet P, Loirat C. WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis. Kidney Int , 2000, 57(5): 1868-1872. [29] Shimoyama H, Nakajima M, Naka H, Park YD, Hori K, Morikawa H, Yoshioka A. A girl with bilateral ovarian tumours: Frasier syndrome. Eur J Pediatr , 2002, 161(2): 81-83. [30] Melo KFS, Martin RM, Costa EMF, Carvalho FM, Jorge AA, Arnhold IJP, Mendonca BB. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J Clin Endocrinol Metab , 2002, 87(6): 2500-2505. [31] Pérez de Nanclares G, Castaño L, Bilbao JR, Vallo A, Rica I, Vela A, Martul P. Molecular analysis of Frasier syndrome: mutation in the WT1 gene in a girl with gonadal dysgenesis and nephronophthisis. J Pediatr Endocrinol Metab , 2002, 15(7): 1047-1050. [32] Subbiah V, Huff V, Wolff JEA, Ketonen L, Lang FF Jr, Stewart J, Langford L, Herzog CE. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome. Pediatr Blood Cancer , 2009, 53(7): 1349-1351. [33] Barbaux S, Niaudet P, Gubler MC, Grünfeld JP, Jaubert F, Kuttenn F, Fékété CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet , 1997, 17(4): 467-470. [34] Okuhara K, Tajima S, Nakae J, Sasaki S, Tochimaru H, Abe S, Fujieda K. A Japanese case with Frasier syndrome caused by the splice junction mutation of WT1 gene. Endocr J , 1999, 46(5): 639-642. [35] Kikuchi H, Takata A, Akasaka Y, Fukuzawa R, Yoneyama H, Kurosawa Y, Honda M, Kamiyama Y, Hata J. Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome? J Med Genet , 1998, 35(1): 45-48. [36] Bönte A, Schröder W, Denamur E, Querfeld U. Absent pubertal development in a child with chronic renal failure: the case of Frasier syndrome. Nephrol Dial Transplant , 2000, 15(10): 1688-1690. [37] Kohsaka T, Tagawa M, Takekoshi Y, Yanagisawa H, Tadokoro K, Yamada M. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum Mutat , 1999, 14(6): 466-470. [38] Finken MJ, Hendriks YM, van der Voorn JP, Veening MA, Lombardi MP, Rotteveel J. WT1 deletion leading to severe 46, XY gonadal dysgenesis, Wilms tumor and gonadoblastoma: case report. Horm Res Paediatr , 2015, 83(3): 211-216. [39] Jo A, Denduluri S, Zhang BS, Wang ZL, Yin LJ, Yan ZJ, Kang R, Shi LL, Mok J, Lee MJ, Haydon RC. The versatile functions of Sox9 in development, stem cells, and human diseases. Genes Dis , 2014, 1(2): 149-161. [40] Jaubert F, Galmiche L, Lortat-Jacob S, Fournet JC, Fellous M. Foxl-2 in gonad development and pathology. Arkh Patol , 2011, 73(4): 10-13. [41] Vetro A, Ciccone R, Giorda R, Patricelli MG, Della Mina E, Forlino A, Zuffardi O. XX males SRY negative: a confirmed cause of infertility. J Med Genet , 2011, 48(10): 710-712. [42] Hersmus R, Kalfa N, de Leeuw B, Stoop H, Oosterhuis JW, de Krijger R, Wolffenbuttel KP, Drop SLS, Veitia RA, Fellous M, Jaubert F, Looijenga LHJ. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol , 2008, 215(1): 31-38. [43] Buell-Gutbrod R, Ivanovic M, Montag A, Lengyel E, Fadare O, Gwin K. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas. Pediatr Dev Pathol , 2011, 14(5): 391-395. [44] Lau YFC. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet , 1999, 64(4): 921-927. [45] Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development , 1987, 101(Suppl.): 151-155. [46] Kersemaekers AMF, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, Bokemeyer C, Li YM, Lau YFC, Oosterhuis JW, Looijenga LHJ. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol , 2005, 36(5): 512-521. [47] Li YM, Vilain E, Conte F, Rajpert-De Meyts E, Lau YFC. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Urol Oncol , 2007, 25(2): 141-146. [48] Schubert S, Schmidtke J. Transgenic mouse studies to understand the regulation, expression and function of the testis-specific protein Y-encoded ( TSPY ) gene. Genes , 2010, 1(2): 244-262. [49] Skawran B, Schubert S, Dechend F, Vervoorts J, Nayernia K, Lüscher B, Schmidtke J. Characterization of a human TSPY promoter. Mol Cell Biochem , 2005, 276(1-2): 159-167. [50] Kido T, Lau YFC. The Y-located gonadoblastoma gene TSPY amplifies its own expression through a positive feedback loop in prostate cancer cells. Biochem Biophys Res Commun , 2014, 446(1): 206-211. [51] Shen Y, Yan YL, Liu YQ, Zhang SZ, Yang D, Zhang P, Li L, Wang Y, Ma YX, Tao DC, Yang Y. A significant effect of the TSPY1 copy number on spermatogenesis efficiency and the phenotypic expression of the gr/gr deletion. Hum Mol Genet , 2013, 22(8): 1679-1695. [52] Kandalaft LE, Zudaire E, Portal-Núñez S, Cuttitta F, Jakowlew SB. Differentially expressed nucleolar transforming growth factor-β1 target (DENTT) exhibits an inhibitory role on tumorigenesis. Carcinogenesis , 2008, 29(6): 1282-1289. [53] Hersmus R, Stoop H, van de Geijn GJ, Eini R, Biermann K, Oosterhuis JW, DHooge C, Schneider DT, Meijssen IC, Dinjens WNM, Dubbink HJ, Drop SLS, Looijenga LHJ. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas. PLoS One , 2012, 7(8): e43952. [54] Changchien YC, Haltrich I, Micsik T, Kiss E, Fónyad L, Papp G, Sápi Z. Gonadoblastoma: Case report of two young patients with isochromosome 12p found in the dysgerminoma overgrowth component in one case. Pathol Res Pract , 2012, 208(10): 628-632. [55] Hersmus R, Stoop H, Turbitt E, Oosterhuis JW, Drop SL, Sinclair AH, White SJ, Looijenga LH. SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotype. BMC Med Genet , 2012, 13: 108. [56] Ono M, Harley VR. Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol , 2013, 9(2): 79-91. [57] Wermann H, Stoop H, Gillis AJ, Honecker F, van Gurp RJ, Ammerpohl O, Richter J, Oosterhuis JW, Bokemeyer C, Looijenga LH. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. J Pathol , 2010; 221(4): 433-442. [58] Gimelli G, Giorda R, Beri S, Gimelli S, Zuffardi O. A 46, X, inv(Y) young woman with gonadal dysgenesis and gonadoblastoma: Cytogenetics, molecular, and methylation studies. Am J Med Genet A , 2006, 140A(1): 40-45. [59] Nishino K, Hattori N, Tanaka S, Shiota K. DNA methylation-mediated control of Sry gene expression in mouse gonadal development. J Biol Chem , 2004, 279(21): 22306-22313. [60] Tachibana M. Epigenetic regulation of mammalian sex determination. J Med Invest , 2015, 62: 19-23. [61] Wilhelm D, Martinson F, Bradford S, Wilson MJ, Combes AN, Beverdam A, Bowles J, Mizusaki H, Koopman P. Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. Dev Biol , 2005, 287(1): 111-124. [62] 程汉华, 周荣家. 胚胎早期的发育选择: 性别决定. 遗传, 2007, 29(2): 145-149. [63] 李萌, 贺竹梅. 遗传学教学中性别决定关键基因的阐述. 遗传, 2014, 36(6): 611-617. [64] Li YM, Tabatabai ZL, Lee TL, Hatakeyama S, Ohyama C, Chan WY, Looijenga LHJ, Lau YFC. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum Pathol , 2007, 38(10): 1470-1481. [65] Patel PR, Pappas J, Arva NC, Franklin B, Brar PC. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy. J Pediatr Endocrinol Metab , 2013; 26(9-10): 971-974. [66] Quinonez SC, Park JM, Rabah R, Owens KM, Yashar BM, Glover TW, Keegan CE. 9p partial monosomy and disorders of sex development: review and postulation of a pathogenetic mechanism. Am J Med Genet A , 2013, 161A(8): 1882-1896. [67] Esin S, Baser E, Kucukozkan T, Magden HA. Ovarian gonadoblastoma with dysgerminoma in a 15-year-old girl with 46, XX karyotype: case report and review of the literature. Arch Gynecol Obstet , 2012, 285(2): 447-451. [68] Bai ST, Wei S, Ziober A, Yao Y, Bing ZY. Expression of SALL4 and SF-1 in gonadoblastoma: useful markers in the identification of the invasive germ cell component. Int J Gynecol Pathol , 2013, 32(4): 379-383. [69] Morel Y, Roucher F, Mallet D, Plotton I. Genetic of gonadal determination. Ann Endocrinol , 2014, 75(2): 32-39. |